ACOG/LinkedIn
Oct 15, 2025, 09:08
ACOG Publishes Clinical Update on Postpartum Zuranolone Therapy
American College of Obstetricians and Gynecologists (ACOG) shared a post on LinkedIn:
“ACOG’s latest Clinical Practice Update makes finding the guidance you need on treating depression with zuranolone during the postpartum period easier to find, understand, and put into practice, with clear recommendations, implementation considerations, and more. The guidance also answers questions about clinical scenarios that may arise when considering zuranolone and includes newly available data about concentrations of zuranolone in human milk. Read the guidance.”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 20, 2025, 10:57Clare Pin-Chia Huang: New Research Links Maternal Diabetes to Pregnancy Risks
-
Dec 20, 2025, 10:53Evaluating Maternal and Neonatal Health in Rheumatoid Arthritis Pregnancies – Hiroki Ozawa
-
Dec 20, 2025, 10:36Enhancing Care for Women Facing Recurrent Pregnancy Loss – SOGC
-
Dec 20, 2025, 05:00Ilana Ferhadian: Celebrating Book Launch
-
Dec 19, 2025, 16:21Launch of National Fertility Plan Marks Public Health Milestone – Collectif BAMP Association
-
Dec 18, 2025, 13:55Insights from Cendrine Siraudin on Fertility Support – Destination Santé
-
Dec 18, 2025, 13:34Alberto Sifuentes Giraldo: Key Insights on Antiphospholipid Syndrome From Recent Study
-
Dec 18, 2025, 13:28New Webinar on Managing Bipolar Disorder in Perinatal Patients – The Periscope Project Perinatal Specialty Consult Psychiatry
-
Dec 18, 2025, 13:16New Score Quantifying Disease Activity in Patients With Antiphospholipid Syndrome – EULAR